STOCKS TELEGRAPH

Tag: NNOX

  • Nanox Imaging Reports Surge After FDA Clearance for AI Software

    Nanox Imaging Ltd. (NASDAQ: NNOX) experienced a notable surge in its stock price today, following a robust trading day with a 6% climb and an even more remarkable 83% after-hours performance. The surge occurred subsequent to the company obtaining FDA clearance for its HealthFLD artificial intelligence (AI) software.

    Unlocking HealthFLD’s Potential

    This surge coincides with NNOX receiving 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its HealthFLD AI software. HealthFLD is tailored to provide automated qualitative and quantitative analysis of liver attenuation from routine chest and abdomen CT scans. This aids clinicians in identifying fatty liver, a significant indicator of metabolic dysfunction-associated steatotic liver disease (MASLD).

    Addressing an Ongoing Health Issue

    MASLD, formerly known as non-alcoholic fatty liver disease (NAFLD), affects around 24% of U.S. adults and is closely linked with obesity, cardiovascular disease, and type 2 diabetes. Timely diagnosis of MASLD is critical, as it can lead to severe liver complications if left untreated.

    Future Outlook and Collaborative Efforts

    The FDA clearance for HealthFLD represents a significant advancement in non-invasive diagnostic tools for liver-related diseases. NNOX’s CEO, Erez Meltzer, highlighted HealthFLD’s potential to facilitate the identification of candidates for clinical trials, particularly for metabolic diseases like MASLD and metabolic dysfunction-associated steatohepatitis (MASH).

    Investor Confidence and Strategic Partnerships

    The FDA’s endorsement underscores Nanox’s dedication to developing state-of-the-art AI solutions for population health management. HealthFLD’s clearance supplements Nanox’s existing suite of AI-powered solutions, including HealthCCSng and HealthOST.

    Moreover, the disclosure of Nvidia’s stake in NNOX has likely bolstered investor interest in the company.

    Conclusion

    The approval of HealthFLD represents a significant stride in combatting MASLD and related conditions. Nanox Imaging’s innovative technology holds promise for revolutionizing the diagnosis and management of liver diseases, offering potential improvements in patient outcomes and healthcare efficiency.

  • Why shares of Nano-X Imaging Ltd. (NNOX) surged in premarket?

    Nano-X Imaging Ltd. (NNOX) stock soared 62.93% at $67.34 in premarket trading hours on the last check Thursday. The stock of NNOX lost -0.29% to complete the last trading session at $41.33.

    Nano-X Imaging Ltd ‎(NNOX), an innovative medical imaging technology company which aims for mass deployment of cost reduced imaging systems, notified that its single-source Nanox. ARC digital x-ray technology has been given 510(k) Approval from the FDA, after which NNOX stock surged substantially. NANO-X is also expected to put forward another application for its multi-source Nanox Arcand the NanoxCloud, this year. If approved, the multisource NanoX ARC will be commercialized and sold globally.

    “Obtaining 510(k) clearance from the FDA for our single-source Nanox.ARC digital x-ray is a significant step forward along our US regulatory pathway,” Concluded Ran Poliakine, CEO Nanox.

    NNOX Distinctive Competency Over Its Peers

    NNOX, founded by Ran Poliakine, is an Israel based corporation manufacturing a commercial-grade digital X-ray source which will be immensely significant for improved affordable medical imaging.

    Nanoxplans for its unique technology to decrease the costs of medical imaging systems and aims for partnerships with several healthcare organizations for low cost, and an early detection medical imaging service. NNOX stock has aimed to finalize a minimum distribution of 15,000 Nanox ARC systems by the end of 2024.

    Conclusion

    NANO-X imaging has invested in a very lucrative market of Medical imaging especially amongst the time of a pandemic. NNOX stock has pioneered affordable quality medical imaging and approval by FDA may prove to be extremely significant in further diversifying their income stream and providing income stability as well as a financial surplus, with the company keen on producing results.

  • 3 Stocks Braving Market Selloff after Trump Tests Positive for COVID-19

    3 Stocks Braving Market Selloff after Trump Tests Positive for COVID-19

    Equity markets have fallen sharply today all over the world. In the U.S, key indices are all in the red pointing to a potentially weak close to the week. In pre-market trading, the NASDAQ is down by 2%, the S&P 500 by 1.55%, and the Dow Jones by 1.46%.

    This follows news that the U.S president had tested positive for COVID-19. The president announced via twitter that together with his wife, they had tested positive for the virus and that they had started quarantine. This has thrown the markets into a spin as it indicates just how serious and unrelenting the virus is. It is also noteworthy that the number of infections continues to rise globally, and some countries have returned to strict lockdown measures shortly after easing them up.

    The number of deaths continues to rise too and recently crossed the one million mark. This points to a prolonged period of a disrupted global economy that could remain unstable until a vaccine is found. The worst part is that the news of the president contracting the virus has come just weeks to an election after a highly emotive campaign. However, even as overall market momentum points to weakness, there are stocks that are braving the selloff and doing quite well. Some of the pre-market gainers that could outperform the market today are as below:

    Nano-X Imaging Ltd [NASDAQ: NNOX]

    Nano-X Imaging Ltd is quite strong pre-market and is up by over 25%. This follows news that the company would do a live demonstration of its new imaging system at the RSNA 2020, between November 29th and December 5th. The company’s demonstration will incorporate a tech section for the company’s first commercial digital X-Ray that would be followed by a demonstration of the system handling both 2D and 3D procedures. The CEO said that they were excited about the demonstration as it exposed the growing depth of the company’s technology.

    Xtant Medical Holdings [NYSE: XTNT]

    Xtant Medical Holdings Inc is another top performer this morning and is up by over 100% in performer this morning.  This follows the company’s announcement that it had completed its debt restructuring process. The company stated that the goal of the restructuring is to cut down on total debt and help the company access the capital markets for future growth.

    Lonestar Resources U.S Inc [NASDAQ: LONE]

    Lonestar Resources U.S Inc is another top gainer today and is up by over 100%. This comes despite a downgrade of the company by Moody’s to D-PD after it filed for bankruptcy.

  • Why Nano-X Imaging Ltd. (NASDAQ: NNOX) Stock Soared?

    Why Nano-X Imaging Ltd. (NASDAQ: NNOX) Stock Soared?

    Shares of Nano-X Imaging Ltd. (NASDAQ: NNOX) were up 32.87% as it has announced a partnership with South-Korean chipmaker SK Hynix Inc. to build machines that changed the century-old X-ray industry. Nano-X Imaging aimed to transform the medical devices industry which used the same old technology since the discovery of X-rays in the late-19th century.

    Nano-X Limited uses semiconductors instead of metal filaments in its devices to generate X-rays. The partnership with the largest chipmaker SK Hynix has provided an opportunity to Nano-X to bring new technologies. Nano-X has devices that produce less radiation and are cheaper. Nano-X devices will be able to disrupt the traditional system as they cannot only reduce radiation, improve images but also provide access for more patients.

    Nano-X has earlier signed an exclusive distribution agreement with SPI Medical for the deployment and introduction of Nanox’s medical imaging services in Mexico. Nanox will offer the Nanox Systems to SPI for pilots in the public and private sectors. This company has a unique technology and has a strong business model.

    Nano-X Imaging (NASDAQ: NNOX) shares went up 32.87% as it gained +15.88 during the trading session of Friday. Nano-X Imaging share price went from a low point around $20.25 to briefly over $49.25 in the past 52 weeks, though shares have since pulled back to $64.19. Nano-X market cap has remained high, hitting $2.23 billion at the time of writing. It has moved up 216.91% and 30.34% from its 52-weeks low and 52-weeks high, respectively.

    Nanox has a solution that has the ability to revolutionize the medical devices industry. Its new technology could reduce the cost of medical imaging systems and is striving to work with many organizations and companies to provide affordable technologies to customers. As the world lack access to diagnostic imaging, it has aimed to supply 4,500 units in various countries. It has also decided to join forces with the Foxconn Technology group for the mass production. It has also submitted applications to FDA for the approval.

    Nano-X Imaging has a vision called 1x1x1 aimed at establishing enough systems globally that every person on the planet has access to at least one medical imaging scan each year. Nanox is scheduled to participate in two upcoming investor conferences including Cantor Virtual Global Healthcare Conference and Jefferies Asia Forum on September 15 and September 16, respectively.

  • Top 15 Best Performing Medical Device Manufacture Companies Of 2020

    Top 15 Best Performing Medical Device Manufacture Companies Of 2020

    New medical innovations are emerging day by day and are playing a major role in the health care sector. Much of the credit for these new technological innovations go to the medical devices industry. Technological advancement is continuously changing the medical devices industry. The medical devices that provide and analyze data of patients within minutes are aiding the healthcare organizations to improve patients outcomes, lower costs, and enhance efficiency.

    2020 is the year of challenges and opportunities for many industries including the medical devices industry. The medical device industry is growing with fast speed and it doesn’t seem like it is going to be slowing down anytime soon. The growth in the medical devices industry has occurred because of increasing severe disease with the increasing population. These new diseases need new treatments that can reduce the symptoms in patients. The medical devices industry is important to patients for many reasons. Medical devices companies engaged in the innovations of new technologies that are helpful for patients with chronic diseases.

    Here are the top 15 leading players in the medical devices industry you should be holding right now:

    SmileDirectClub Inc. (NASDAQ: SDC)

    SmileDirectClub Inc. (NASDAQ: SDC) last closed at $11.27, in a 52-week range of $3.64 to $21.10. Analysts have a consensus price target of $10.08. SmileDirectClub Inc. (SDC) has partnered with Meredith Corporation (MDP) to introduce Telehealth Explained. Telehealth Explained is the new platform aimed to educate consumers about the many benefits of telehealth for physical, mental, and dental health.  SmileDirectClub Inc.’s market cap has remained high, hitting $4.66 billion at the time of writing.

    CHF Solutions Inc. (CHFS)

    CHF Solutions Inc. (CHFS) stock soar by 5.85% to $0.32. CHF Solutions Inc. (CHFS) has earlier disclosed that it has received 180-extension to meet the Nasdaq minimum bid price requirement. The company has now the time since February 24, 2021, to meet all the requirements.  CHFS has earlier hosted the interactive, physician-led webinar to discuss “Precision Medicine for the Treatment of Fluid Overload in Patients with Acute Heart Failure.” CHF Solutions has a 52-weeks low and high range of $0.28 and a low range of $2.92.

    Abbott Laboratories (NYSE: ABT)

    Abbott Laboratories (NYSE: ABT) stock soar by 2.89% to $105.81. The most recent rating by Goldman, on June 01, 2020, is at a Sell. Abbott Laboratories (ABT) has earlier disclosed that it has initiated the LIFE-BTK clinical trial to evaluate the safety and effectiveness of the company’s new Esprit™ BTK Everolimus-Eluting Resorbable Scaffold System.  ABT has a 52-weeks low and high range of $61.61 and $114.19, respectively. It has a market cap of $189.80 billion at the time of writing.

    Avinger Inc. (NASDAQ: AVGR)

    Avinger Inc. (NASDAQ: AVGR) Shares headed rising, higher as much as 3.70%. The most recent rating by Ladenburg Thalmann, on March 09, 2018, is at a Buy. Avinger Inc. (AVGR) has earlier disclosed that the underwriter of its earlier revealed underwritten public offering has practiced, in full, their option to purchase an additional 1,000,000 shares of the Company’s common stock at a price of $0.47 per share. Avinger Inc.’s market capitalization has remained high, hitting $36.67 million at the time of writing.

    InspireMD Inc. (AMEX: NSPR)

    InspireMD Inc. (AMEX: NSPR) fall -7.23% after losing more than -$0.02 on Wednesday. InspireMD Inc. has disclosed that it has received the FDA approval to proceed with a pivotal study of the CGuard Carotid Stent System, CARENET-III, for prevention of stroke in patients in the United States.  The FDA approval of Investigational Device Exemption (IDE) has been proved to be useful for the company as it is now able to conduct the trial to check the potential of CGuard EPS against carotid artery disease.

    BIOLASE Inc. (NASDAQ: BIOL)

    BIOLASE Inc. (NASDAQ: BIOL) last closed at $0.30, in a 52-week range of $0.21 to $1.16. BIOLASE Inc. (BIOL) has disclosed that Todd Norbe, President and CEO, and John Beaver, COO, and CFO, will be providing an overview of the Company, as well as recent progress and achievements at the Colliers & Co.  Institutional Investor Conference on Thursday, September 10, 2020. BIOLASE Inc. has a market capitalization of $26.66 million at the time of writing.

    Stryker Corporation (NYSE: SYK)

    Stryker Corporation (NYSE: SYK) stock soar by 2.66% to $205.41. The most recent rating by Barclays, on April 13, 2020, is at an Underweight. Stryker Corporation (SYK) has earlier revealed that it will take part in the Morgan Stanley 18th Annual Virtual Global Healthcare Conference on Tuesday, September 15, 2020. This company’s market capitalization has remained high, hitting $77.31 billion at the time of writing.

    Livongo Health Inc. (NASDAQ: LVGO)

    Livongo Health Inc. (NASDAQ: LVGO) last closed at $128.03, in a 52-week range of $15.12 to $150.00. Analysts have a consensus price target of $130.41. Livongo Health Inc. (LVGO) disclosed that executives of Livongo Health and the executives from Teladoc Health will be participating in the following upcoming investor conferences. It had a trading volume of 1.72 million as compared to the average volume of 4.89 million.

    Boston Scientific Corporation (NYSE: BSX)

    Boston Scientific Corporation (NYSE: BSX) shares headed rising, higher as much as 1.49% after Boston Scientific Launches Vercise Genus™ DBS System In Europe. The most recent rating by SVB Leerink, on April 22, 2020, is at an Mkt perform. Boston Scientific Corporation (BSX) has a 52-weeks low and high range of $24.10 and $46.62, respectively. It has a market cap of $59.43 billion at the time of writing.

    Medtronic plc (NYSE: MDT)

    Medtronic plc (NYSE: MDT) rose 1.99% after gaining more than $2.08 on Wednesday. Medtronic Receives Breakthrough Device Designation from FDA, Begins Early Feasibility Study for Investigational Intrepid™ Transcatheter Valve System for the Treatment of Tricuspid Valve Regurgitation. Medtronic plc (MDT) has traded up 47.87% from its 52-weeks low and traded down -12.68% from its 52-weeks high.

    Ra Medical Systems Inc. (RMED)

    Ra Medical Systems Inc. (RMED) last closed at $0.25, in a 52-week range of $0.26 to $2.69. Ra Medical Systems to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 16. Ra Medical Systems Inc. (RMED) has traded down -2.46% from its 52-weeks low and traded down 90.57% from its 52-weeks high.

    Hancock Jaffe Laboratories Inc. (NASDAQ: HJLI)

    Hancock Jaffe Laboratories Inc. (NASDAQ: HJLI) shares were trading up 12.80% at $0.41 at the time of writing on Wednesday. Hancock Jaffe Laboratories Inc. (NASDAQ: HJLI) share price went from a low point around $0.21 to briefly over $1.03 in the past 52 weeks, though shares have since pulled back to $0.41. HJLI market cap has remained high, hitting $16.12M at the time of writing.

    Nano-X Imaging Ltd. (NASDAQ: NNOX)

    Nano-X Imaging Ltd. (NASDAQ: NNOX) shares headed rising, higher as much as 7.76% after Nanox Signs Agreement With SPI Medical for the Deployment of 630 Nanox. Its stock has fluctuated between the 52-weeks low of $20.25 and a 52-weeks high range of $43.48. NNOX has moved up 117.33% and 1.24% from its 52-weeks low and high, respectively. Its market capitalization has remained high, hitting $2.08 billion.

    Edwards Lifesciences Corporation (NYSE: EW)

    Edwards Lifesciences Corporation (NYSE: EW) rose 3.26% after gaining more than $2.68 on Wednesday. Edwards Lifesciences Corporation (EW) stock has fluctuated between the 52-weeks low of $51.51 and a 52-weeks high range of $87.79. EW has moved up 64.72% from its 52-weeks low and moved down -3.36% from its 52-weeks high, respectively. Its market capitalization has remained high, hitting $54.00 billion.

    Wright Medical Group N.V. (NASDAQ: WMGI)

    Wright Medical Group N.V. (NASDAQ: WMGI) stock drop by -0.26% to $30.30. The most recent rating by Jefferies, on December 24, 2019, is at a Hold. Wright Medical Group N.V. (WMGI) has a 52-weeks low and high range of $19.04 and $30.66, respectively. It has a market capitalization of $2.92 billion.